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E-mail address: zhangaili@tju.edu.cn (A. Zhang).In Saccharomyces cerevisiae PKA plays a major role in regulating cell growth, metabolism, and stress
resistance. We report that Sch9 regulates PKA directly and SCH9 deletion enhances PKA activity by
showing that: (1) Bcy1 predominately localized in the nucleus in glycerol-grown sch9D cells; (2)
large part of the catalytic subunits of PKA transferred from the nucleus to the cytoplasm in sch9D
cells; (3) higher protein stability of Tpk2 resulted in higher protein level of Tpk2 in sch9D than in
wild type cells. Our investigations suggest that Sch9 regulates phosphorylation of Bcy1. We also
observed hyper-phosphorylation of Cdc25 in sch9D, in contrast to the tpk2D and tpk2Dsch9D
mutants, suggesting that feedback inhibition of PKA on Cdc25 is through Tpk2.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
All organisms sense and respond to nutrient derived signals to
adapt their physiology and adopt appropriate developmental deci-
sions to promote survival. In the yeast Saccharomyces cerevisiae (S.
cerevisiae), glucose signals activate the production of cellular
cAMP. This signaling pathway is called the Ras-cAMP pathway,
which plays a major role in the regulation of cell growth, metabo-
lism and stress resistance, in particular in connection with the
available nutrient conditions [1]. The level of cAMP is controlled
by an elaborate pathway of which many components have been
identiﬁed. cAMP is synthesized by adenylae cyclase encoded by
the CYR1/CDC35 gene [2]. The activity of adenylae cyclase is
controlled by Ras proteins and Gpr1-Gpa2. The Ras protein is a
small G protein that demonstrates its biological functions through
a cycle of GDP/GTP exchange and GTP hydrolysis. The GTP-bound
form is active while the hydrolysis of the bound GTP to GDP inac-
tivates it. The GDP/GTP exchange on the Ras protein is catalyzed by
Cdc25 [3] and the GTP hydrolysis reaction is stimulated by Ira1 and
Ira2 [4]. GPR1 encodes a glucose receptor molecule with seven
transmembrane regions, and the third cytosolic loop and C-termi-
nal end were shown to interact with Gpa2 [5]. Cellular cAMP is
hydrolyzed by low-afﬁnity (Pde1) [6] and high-afﬁnity (Pde2) [7]
cAMP phosphodiesterases through which can realize the feedback
inhibition on PKA [8,9].chemical Societies. Published by EThe downstream target of cAMP in yeast is PKA which is a tet-
ramer consisting of two regulatory subunits (encoded by the gene
BCY1) and two catalytic subunits (encoded by the genes TPK1, TPK2
and TPK3) [10]. Although the three genes (TPK1, TPK2, and TPK3)
play redundant roles during cell growth [11], distinct roles have
been shown for each subunit in pseudohyphal growth. cAMP con-
trols the localization of Tpk1, and the carbon source determines
that of Bcy1 [12]. During exponential growth on glucose, both
Bcy1 and Tpk2 localized in nucleus, whereas Tpk1 and Tpk3
showed a mixed pattern of nucleus-cytoplasm localization. During
exponential growth on glycerol and during stationary phase, the
PKA subunits showed mostly cytoplasmic localization [13]. The
N-terminal domain of Bcy1 served to target it properly during log-
arithmic phase and stationary phase [12].
Another pathway involved in signaling the presence of glucose
and nitrogen to yeast cells is the so-called Fermentable Growth
Medium (FGM) induced pathway [14]. Protein kinase Sch9, an
orthologue of mammalian PKB/Akt, is one of major components
of this pathway. Sch9 plays an important role in nitrogen signaling
and glucose signaling in the budding yeast. When Sch9 was
deleted, the activity of the protein kinase A in derepressed cells
was strongly elevated and this was supported both by in vivo mea-
surements of protein kinase A targets and by direct in vitro mea-
surements of its activity [14], but the mechanism is still unclear.
Subsequent studies showed that Sch9 was an activator of transla-
tion initiation, the expression of ribosomal protein, ribosome
biogenesis genes, a regulator of cell size control and transcription
in response to nutrient availability and osmotic stress responses
[14–18]. Sch9 also participated in a conserved signaling networklsevier B.V. All rights reserved.
Table 1
Strains used in this study.
Strains Genotype Source or
reference
W303-
1A
MATa leu2-3, 112 ura3-1 trp1-92 his3-11,15 ade2-1
can1-100
Wild type
[22]
ZAL640 MATa sch9D::URA3 This study
ZAL103 MATa tpk1D::repeat CDC25-3xHA This study
ZAL102 MATa tpk2D::repeat CDC25-3xHA This study
ZAL101 MATa tpk3D::repeat CDC25-3xHA This study
ZAL503 MATa tpk1D::repeat sch9D::URA3 CDC25-3xHA This study
ZAL502 MATa tpk2D::repeat sch9D::URA3 CDC25-3xHA This study
ZAL501 MATa tpk3D::repeat sch9D::URA3 CDC25-3xHA This study
DJ401 MATa CDC25-3xHA This study
DJ404 MATa sch9D::URA3CDC25-3xHA This study
Table 2
Plasmids used in this study.
Plasmids Source or reference
YCplac22 [23]
YEplac112 [23]
pUC18-RYUR [24]
YCplac22-GFP-BCY1 This study
YCplac22-BCY1-3xHA This study
YCplac22-TPK1-GFP This study
YCplac22-TPK1-3xHA This study
YCplac22-TPK2-GFP This study
YCplac22-TPK2-3xHA This study
YEplac112-TPK3-GFP This study
YEplac112-TPK3-3xHA This study
Table 3
Primers used in this study.
Primer Oligonucleotide
50BCY1-U 50GGTACCAAGCTTAAGAGGAGCATACGACTTCG30
50BCY1-D 50GGTACCGGATCCCATCGTTTATTCTTACTGTTGTC30
30BCY1-U 50GGTACCGGATCCGTATCTTCTTTGCCCAAGGA30
30BCY1-D 50GGTACCGAATTCCGGAATCTTTCTGTGTGGAT30
ZBCY1-U 50CCCGGGGGATCCAAGAGGAGCATACGACTTCG30
bcy1gfp-D 50GAGCTCCGGCCGCATGTCTTGTAGGATCATTGAGC30
CTPK1-U 50CCCGGGGGATCCACATACCGGTATACACCACA 30
CTPK1-D 50CCCGGGGCATGCGAAGTCCCGGAAAAGATCAG30
CTPK2-U 50CCCGGGGGATCCAGCTGGCCAGTCAATTTGGT30
tpk2gfp-D 50GAGCTCGCGGCCGCGAAATCTTGAAAGTATTCAGC30
CTPK3-U 50GTCGACCCCGGGCAGATACTCTCTGGTGCGCA30
CTPK3-D 50GTCGACGCATGCAAATTCTTTCATTAAATCCATA
TATGGATCCTCCCC30
Relevant restriction sites are underlined.
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Thr570 in the activation loop of Sch9, and Tor1/2, which phosphor-
ylated six amino acids in the C terminus of Sch9 and these phos-
phorylation events were required for catalytic activity [19–21].
In S. cerevisiae, as well as in higher eukaryotes, highly conserved
protein kinase PKA and Sch9 integrate the nutrient and other envi-
ronmental cues to regulate ribosome biogenesis, stress response,
cell size, autophagy, and other cellular processes [22]. In recent
years, the general understanding of multiple ways of crosstalk
between PKA and Sch9 have greatly advanced [23]. However, the
ﬁne mechanisms of how Sch9 regulate Ras-cAMP pathway remains
need to be clariﬁed.
Here we report that Sch9 inhibits PKA activity. We observed
that Sch9 regulated the localization and phosphorylation of Bcy1,
and there were more Tpk1, Tpk2, Tpk3 localized in cytoplasmic
in sch9D cells than in wild type cells. Most importantly, we found
that higher protein stability of Tpk2 in sch9D cells resulted in high-
er protein level of Tpk2 in sch9D cells. All these results suggested
that deletion of SCH9 enhanced PKA activity. Our researches also
demonstrated that deletion of SCH9 resulted in hyper-phosphory-
lation of Cdc25, while this hyper-phosphorylation of Cdc25 disap-
peared in tpk2D mutant and sch9Dtpk2D mutant. These results
suggested that Sch9 regulated phosphorylation of Cdc25 though
Tpk2 to realize feedback inhibition on Ras-cAMP signal pathway.
2. Materials and methods
2.1. Yeast strains, growth media, growth conditions and plasmids
Yeast strains used in this study were listed in Table 1. Yeast
cells were grown in YPD (1% (w/v) yeast extract, 2% (w/v) peptone
and 2% (w/v) glucose) or in synthetic complete (SC) medium
(0.17% (w/v) nitrogen base, with adenine, uracil, histidine, leucine,
tryptophan and amino acids as appropriate) but lacking essential
components to select for plasmids. Yeast cells were grown into
mid-exponential phase (OD600 1.5) at 30 C. Carbon source-
derepressed cells used for the experiments described in this study
were grown on YPG (1% (w/v) yeast extract, 2% (w/v) peptone and
3% (w/v) glycerol)) until the cultures reached an OD600 of 1.5. To
obtain cells in stationary phase, cells were cultured in YPD for at
least 2 days.
All plasmids and primers used in this study were listed in Tables
2 and 3, respectively.
2.2. Western blot analysis
Yeast cells cultures were grown at 30 C. Cells were harvested
by centrifugation at 4 C and washed in ice-cold sterile water,
and then the pellets were stored at80 C until use. All subsequent
steps were carried out at 4 C. Cells were resuspended in lysis
buffer containing 50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 5 mM
EDTA, 0.1% NP-40/Igepal CA-630, 1 mM phenylmethylsulfonyl
ﬂuoride (PMSF), 10 mM NaF, 1 mM sodium orthovanadate ,
10 mM glycerol-2-phosphate, and a mixture of protease inhibitors
(Roche). And then cells were disrupted by vortexing them for 30s
in the presence of glass beads using Fastprep FP120 (Bio101 Ther-
mo Savant). The resulting suspensions were spun down in a centri-
fuge at 18000g for 5 min. After addition of equal volume of 2
sample buffer to the supernatant, samples were heated to 95 C
for 5 min before equal amount of total protein being separated
by SDS–PAGE. Immunodetection of proteins were carried out using
anti-hemagglutinin (HA) monoclonal antibody (mouse immuno-
globulin G [IgG3], TIANGEN) or Anti-GAPDH Antibody (HRP conju-
gated) (mouse monoclonal antibody, TIANGEN) as loading control.
The secondary antibody was anti-mouse IgG conjugated withhorseradish peroxidase purchased from TIANGEN. Proteins were
visualized using LumiGlo (KPL) according to the manufacturer’s
instructions.
2.3. Quantitative RT-PCR assays
Total RNA were isolated from cells (1  107) using the RNA
Extraction Kit (TIANDZ, China) and RNA concentrations were deter-
mined by measuring absorbance at 260 nm. From 1 lg of total
RNA, ﬁrst-strand cDNA were prepared with Quantscript RT Kit
(TIANGEN, China) using oligio-dT15 primer. Relative quantiﬁcation
of TPK2 and ACT1mRNA were determined with the RealMasterMix
(SYBR Green) qPCR kit (TIANGEN, China) and the following primers
for TPK2: For, 50ATGGAATTCGTTGCAGAAAGG30 and Rev, 50ACG
CCTTGCCCGTAAGTA30. For ACT1 the primers were: For, 50TTATTG
ATAACGGTTCTGGTATG30 and Rev, 50CCTTGGTGTCTTGGTCTAC30.
Real-time quantitative RT-PCR (Q-RT-PCR) assays were performed
Fig. 1. Effect of Sch9 on cAMP level after addition of 100 mM glucose to glycerol-
grown wild type () and sch9D (N) cells.
Fig. 2. Effect of Sch9 on localization and phosphorylation of Bcy1. (A) Localization
of GFP-Bcy1 in exponential phase wild type cells and sch9D mutant cells. Cells
carrying GFP-Bcy1 were used for ﬂuorescence microscopy directly without ﬁxation.
(B) Expression of Bcy1 in wild type and sch9D mutant at exponential phase and
stationary phase (48 h). Proteins were extracted, equal amounts of cellular protein
(30 lg) were separated on a 10% SDS–PAGE gel.
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abundance of TPK2 was determined relative to the standard tran-
script of ACT1 and the ﬁnal data of relative gene expression were
calculated following the 2-DDCt method, as described in [24].
2.4. Green ﬂuorescence protein (GFP) ﬂuorescence microscopy
Cells were used for ﬂuorescence microscopy directly without
ﬁxation. Cells were viewed using an Olympus BX51 ﬂuorescence
microscope. Images were taken with an Olympus U-LH100HGAPO
camera using SPOT (Version 4.0.2) software and then processed in
Adobe Photoshop CS4.
3. Results
3.1. Sch9 regulated localization and phosphorylation of Bcy1
It was reported that addition of 100 mM glucose to glycerol-
grown wild type cells caused a transient increase in cAMP level
[14]. But this glucose-induced cAMP increase of sch9D cells
decreased signiﬁcantly than that of wild-type cells (Fig. 1), this is
consistent with early research [14]. According to Crauwels, M.
and his colleagues’ research, when SCH9 was deleted, the activity
of the protein kinase A in derepressed cells was strongly elevated
and this was supported both by in vivo measurements of protein
kinase A targets and by direct in vitro measurements of its activity
[14]. However, cAMP synthesis and the glucose-induced cAMP
signal are to be down-regulated by high protein kinase activity.
The feedback inhibition of PKA on cAMP synthesis caused the low-
er cAMP level in sch9D strains. But the mechanisms of Sch9 inhibit
PKA activity is still unclear.
To analyze whether Sch9 inhibit PKA directly, we investigated
whether Sch9 regulated the expression and localization of Bcy1.
As shown in Fig. 2A, Bcy1 predominantly localized in nucleus in
rapidly glucose-grown wild type cells and sch9D cells. A large part
of Bcy1 transferred from nucleus to cytoplasm in glycerol-grown
wild type cells, while Bcy1 remained nucleus in glycerol-grown
sch9D cells. These results suggested that Sch9 regulated localiza-
tion of Bcy1.
It was reported that Bcy1 was phosphorylated in cells grown on
nonfermentable carbon source or in stationary phase cells [25].
Phosphorylation of its N-terminal domain directs Bcy1 to
cytoplasm. As shown in Fig. 2B, faster-migrating iso-form ofBcy1-HA was detected in exponential phase wild type cells, while
a predominant slower-migrating iso-form of Bcy1-HA was de-
tected in stationary phase wild type cells. But faster-migrating
iso-form of Bcy1-HAwas detected in sch9Dmutant cells and yak1D
mutant cells-either in exponential phase or in stationary phase.
These indicated that Sch9 might regulate phosphorylation of Bcy1.
3.2. Sch9 regulated the activity and localization of catalytic subunit of
PKA
To further examine how Sch9 regulates PKA, we began to inves-
tigate whether Sch9 affected protein levels and the localization of
catalytic subunits (encoded by the genes TPK1, TPK2, and TPK3) of
PKA. Firstly we determined Tpks protein levels of wild type cells
and sch9D mutant cells. As shown in Fig. 3, protein levels of
Tpk1 and Tpk2 in glycerol-grown wild type cells were higher than
in glucose-grown wild type cells (Fig. 3A and B), while protein level
of Tpk3 in glycerol-grown wild type cells were lower than in
glucose-grown wild type cells (Fig. 3C). As indicated in Fig. 3A,
Tpk1 protein levels of glucose-grown sch9D cells decreased slightly
compared with that of wild type cells, while Tpk1 protein levels of
glycerol-grown sch9D cells did not have great change compared
with that of wild type cells. Fig. 3B suggested that protein levels
of Tpk2 in sch9D cells enhanced markedly than in wild type cells,
especially in glycerol-grown cells. Protein levels of Tpk3 in sch9D
cells decreased slightly compared to wild type cells grown either
on glucose or glycerol (Fig. 3C). All these results suggested that
deletion of SCH9 enhanced PKA activity by increasing protein level
of Tpk2.
To clarify whether Sch9 regulated Tpk2 at transcription level,
mRNA levels of TPK2 of wild type cells and sch9D cells were tested
using quantitative RT-PCR assays (Q-RT-PCR). mRNA levels of TPK2
in glycerol-grown cells was about two to three times than in glu-
cose-grown cells. But mRNA levels of TPK2 in sch9D cells did not
have great change compared with wild type cells (data not shown).
These results indicated that Sch9 did not inhibit Tpk2 activity by
regulating transcription of Tpk2.
Fig. 3. Protein levels of Tpk1, Tpk2 and Tpk3 in glucose-grown and glycerol-grown W303-1A and sch9D cells. Samples were taken from exponential phase (OD600nm 2.0) cells
carrying 3xHA-tagged Tpk1, Tpk2 and Tpk3. Proteins were separated on 10% SDS–PAGE gels. Protein levels of GAPDH were examined as loading control. For quantitative
analysis, band intensities were measured using SCION IMAGE. Normalized intensities (Tpk/GAPDH⁄100) are presented as means ± S.D. of three independent experiments. (A)
Comparison of Tpk1 protein levels in glucose-grown or glycerol-grown W303-1A and sch9D cells carrying single-copy plasmid YCplac22-TPK1-3HA. Equal amounts of
cellular protein (50 lg) were separated on SDS–PAGE. (B) Comparison of Tpk2 protein levels in glucose-grown or glycerol-grown W303-1A and sch9D cells carrying single-
copy plasmid YCplac22-TPK2-3HA. Equal amounts of cellular protein (50 lg) were separated on SDS–PAGE. (C) Comparison of Tpk3 protein levels in glucose-grown or
glycerol-grown W303-1A and sch9D cells carrying multi-copy plasmid YEplac112-TPK1-3HA. Equal amounts of cellular protein (100 lg) were separated on SDS–PAGE.
A. Zhang et al. / FEBS Letters 585 (2011) 3026–3032 3029Then we examined whether the higher Tpk2 protein levels of
sch9D cells were due to protein stability difference. We determined
Tpk2 protein levels in cells treated with protein synthesis inhibitor
cycloheximide (50 lg/ml). As shown in Fig. 4A, Tpk2 protein levels
of glucose-grown wild type cells decreased visibly after adding
protein synthesis inhibitor cycloheximide two hours. While Tpk2
protein levels of cycloheximide-treated-glucose-grown sch9D cells
did not have visible change. These suggested that Tpk2 protein
stability of glucose-grown sch9D celld were higher than that of
wild type cells. According to Fig. 4B, Tpk2 protein levels of glyc-
erol-grown wild type cells decreased visibly after adding protein
synthesis inhibitor cycloheximide two hours. But Tpk2 protein lev-
els of glycerol-grown sch9D cells did not change visibly. All these
indicate that the higher protein levels of Tpk2 in sch9D cells were
due to higher protein stability.
We next tested whether Sch9 had effects on localization of
Tpks. As shown in Fig. 5A, Tpk1-GFP mainly localized in nucleus
of exponential phase glucose-grown wild type cells, only a little
part of Tpk1-GFP mainly localized in cytoplasm. Cytoplasmic local-
ization of Tpk1-GFP in glycerol-grown wild type cells increased
than in glucose-grown cells. While cytoplasmic localization of
Tpk1 in glucose-grown and glycerol-grown sch9D cells increased
markedly than in wild type cells. According to Fig. 5B, Tpk2-GFPpredominantly localized in nucleus of exponential phase glucose-
grown wild type cells, while some part of Tpk2 transferred from
nucleus into cytoplasm in exponential phase glycerol-grown wild
type cells. But Tpk2 predominantly localized in cytoplasm of sch9D
cells either grown on glucose or glycerol. Tpk3-GFP predominantly
localized in nucleus of exponential phase glucose-grown wild type
cells, while part of Tpk3 transferred from nucleus into cytoplasm in
exponential phase glycerol-grown wild type cells. Cytoplasmic
localization of Tpk3 in sch9D cells either grown on glucose or glyc-
erol increased slightly than in wild type cells (Fig. 5C). Together,
these results demonstrated that deletion of SCH9 caused transfer-
ring of Tpks into cytoplasm.
3.3. SCH9 deletion resulted in hyper-phosphorylation of Cdc25
It was reported recently that Cdc25 was hyper-phosphorylated
in strains with higher PKA activity, and that Cdc25 was in lower
phosphorylation level in lower PKA activity strains, while hyper-
phosphorylated Cdc25 have lower GEF (Guanine Nucleotide
Exchange Factor) activity on Ras in vitro [26]. These results suggest
that phosphorylation of Cdc25 by activated PKA is a feedback inhi-
bition mechanism on cAMP signaling. Our results indicate that
deletion of SCH9 caused high PKA activity. In order to investigate
Fig. 4. Analysis of Tpk2 protein stability. Proteins were extracted form W303-1A
and sch9D cells carrying YCplac22-TPK2-3HA grown in YPD or YPG in the presence
or absence of cycloheximide(CHX) (50 lg/ml). Typical results were shown. Band
intensities were quantiﬁed with SCION IMAGE, and the intensity of W303-1A (YPD
or YPG, 0 min) was set to 100, and data are presented as means ± S.D. (A) Analysis of
Tpk2 protein stability in glucose-grown cells. (B) Analysis of Tpk2 protein stability
in glycerol-grown cells.
Fig. 5. Effect of Sch9 on localization of catalytic subunits of PKA. TPK1-GFP, TPK2-
GFP, TPK3-GFP strains were grown until exponential phase of growth on YPD or
YPG. (A) Localization of Tpk1-GFP in wild type and sch9D cells. Cells carrying single-
copy plasmid YCplac22-TPK1-GFP were observed directly without ﬁxation. (B)
Localization of Tpk2-GFP in wild type and sch9D cells. Cells carrying single-copy
plasmid YCplac22-TPK2-GFP were observed directly without ﬁxation. (C) Localiza-
tion of Tpk3-GFP in wild type and sch9D cells. Cells carrying multi-copy plasmid
YEplac112-TPK3-GFP were observed directly without ﬁxation.
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er glucose-induced cAMP signal in sch9D strains, we examine
phosphorylation level of Cdc25 in sch9D cells.
As shown in Fig. 6A, Cdc25 was phosphorylated immediately
after addition of 100 mM glucose to glycerol-grown wild type cells,
while Cdc25 was hyper-phosphorylated in sch9D cells before and
after addition of 100 mM glucose. These results indicate that dele-
tion of SCH9 resulted in high PKA activity which caused hyper-
phosphorylation of Cdc25, while hyper-phosphorylated Cdc25
have lower GEF (Guanine Nucleotide Exchange Factor) activity on
Ras, thus glucose-induced cAMP signal decreased in sch9D cells.
Our results demonstrate that protein levels of Tpk2 increased
markedly in sch9D cells (Fig. 3B), we want to know whether PKA
phosphorylate Cdc25 via Tpk2. As indicated in Fig. 6B and C,
Cdc25 was phosphorylated in wild type cells, tpk1D cells, tpk3D
cells, tpk1Dsch9D cells and tpk3Dsch9D cells after addition of
100 mM glucose, but Cdc25 was not phosphorylated in tpk2D cells
and tpk2Dsch9D cells. These indicate that PKA phosphorylate
Cdc25 via Tpk2.
4. Discussion
4.1. The physiological role of the inhibition of PKA activity by Sch9
Our research conﬁrmed and extended previous work which
suggested that deletion of SCH9 enhanced PKA activity [14] by
showing: (1) Bcy1 predominately localized in nucleus in glycerol-
grown sch9D cells; (2) large part of catalytic subunits of PKA trans-
ferred from nucleus into cytoplasm in sch9D cells; (3) higher
protein stability of Tpk2 resulted in higher protein level of Tpk2
in sch9D cells. Compartmentalization of signal transduction path-
ways is an important additional level of control to ensure sufﬁcientspeciﬁcity in cAMP-PKA signaling. In this way, signaling molecules
of the same pathway are brought into close vicinity, thereby
increasing the probability that they only affect each other appro-
priately. Bcy1 (inhibitor of Tpks) predominantly localize in nucleus
in sch9D cells, while more Tpks transferred from nucleus into cyto-
plasm at different levels. So liberated catalytic subunits are not
restricted by the regulatory subunits and consequently competent
to phosphorylate substrates preferentially located nearby (e.g.,
fructose-1,6-bisphosphatase, trehalase), all these lead to high
PKA activity phenotype of sch9D cells.
Furthermore we demonstrated that the higher protein levels of
Tpk2 in sch9D cells were due to higher protein stability (Fig. 4). The
effect of Sch9 deletion on the stability of Tpk2 protein might result
from direct modiﬁcation of the Sch9 protein by Tpk2, generating a
more stable protein, or from modiﬁcation of a protease(s), which is
responsible for the degradation of Tpk2 protein and makes it less
effective with respect to Tpk2 degradation.
Fig. 6. Effect of SCH9 deletion on phosphorylation of Cdc25: Glu-, extract from
glycerol-grown cells; Glu+, extract from glycerol-grown cells after addition of
100 mM glucose for 30s. Proteins were extracted, equal amounts of cellular protein
(50 lg) were separated on 7% SDS–PAGE gels. Phosphorylated Cdc25 had lower
mobility than unphosphorylated Cdc25 on the blot. (A) Deletion of SCH9 results in
hyper-phosphorylation of Cdc25. (B) Effects of TPK1, TPK2 or TPK3 deletion on
expression of Cdc25 in wild type cells. (C) Effects of TPK1, TPK2 or TPK3 deletion on
expression of Cdc25 in sch9D.
A. Zhang et al. / FEBS Letters 585 (2011) 3026–3032 30314.2. Sch9 regulated localization and phosphorylation of regulatory
subunits Bcy1
Bcy1 predominantly localized in nucleus of rapidly glucose-
grown cells, but distributed over nucleus and cytoplasm in glyc-
erol-grown cells [12]. We found that cytolasmic localization of
Bcy1 were largely absent in glycerol-grown sch9D cells (Fig. 2). It
was reported that Zds1 interact with Bcy1 N-terminal domain, in
ethanol-grown zds1D cells cytolasmic localization of Bcy1 was
largely absent, while overexpression of ZDS1 led to increased cyto-
plasmic Bcy1 localization [27]. Whether Sch9 regulate localization
of Bcy1 directly or via Zds1 needs to be clariﬁed. We also found
that phosphorylation of Bcy1 was deﬁcient in sch9D mutant.
According to Grifﬁoen and his colleagues’ research, Bcy1 modiﬁca-
tion was dependent on Yak1 kinase, and in ethanol-grown yak1D
cells the Bcy1 remained nuclear [27]. Whether Sch9 regulate phos-
phorylation of Bcy1 directly or via Yak1 or other unknown protein
also needs to be investigated.
4.3. Feedback inhibition systems of PKA on cAMP accumulation
Previous studies on feedback control of cAMP level showed that
deletion of the two phosphodiesterase genes in an RAS2val19 strain
caused a signiﬁcant increase in the cAMP level, but in a strain with
attenuated PKA activity there was a similar high cAMP level in
spite of the presence of the phosphodiesterases [28]. This indicates
that high PKA activity in some way is required for efﬁcient break-
down of cAMP by the phosphodiesterases [29]. Studies on the low-
afﬁnity cAMP phosphodiesterase Pde1 and the high-afﬁnity cAMP
phosphodiesterase Pde2 have revealed their speciﬁc functions in
controlling agonist-induced cAMP signaling [8,9].
Our studies demonstrate that Cdc25 was hyper-phosphorylated
in sch9D cells (Fig. 6A). It was reported recently that hyper-phos-
phorylated Cdc25 had lower GEF (Guanine Nucleotide Exchange
Factor) activity on Ras in vitro, and phosphorylation of Cdc25 by
activated PKA was a feedback inhibition mechanism on cAMP sig-
naling [26]. Thus the hyper-phosphorylated Cdc25 had feedback
inhibition on cAMP synthesis and caused the lower glucose-in-
duced cAMP signal in sch9D cells. Our research extended previous
work by showing Cdc25 was not phosphorylated in tpk2D cells andtpk2Dsch9D which suggested that feedback inhibition of PKA on
Cdc25. was through Tpk2.
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